Semaglutide
US$ 29.38
benefits of glp-1 drugs MCT2D Glucagon-like peptide 1 receptor agonists:
Description
The addition of GIP receptor agonism in tirzepatide does not appear to significantly amplify heart rate effects compared to GLP-1-only drugs like semaglutide
M.SweeneyD.OttawayN.et al
JCI Insight (2023)
Patients who are overweight or dealing with PCOS (polycystic ovarian syndrome) probably also have an insulin insensitivity
The high costs, long-term dependency, and insurance complexities make these drugs a hot topic in both the medical and financial sectors
